Please enable JavaScript
Powered by Benchmark Matribhumi Samachar English - Page 754 of 2731 -
Saturday, January 17 2026 | 08:55:44 AM

ONGold Initiates Infill Sampling Program to Recover Missing Tungsten and Gold Assays at Monument Bay for Enhanced Resource Modeling and Development

Toronto, Ontario–(Newsfile Corp. – September 2, 2025) – ONGold Resources Ltd. (TSXV: ONAU) (OTCQB: ONGRF) (“ONGold“) is pleased to announce that the company has initiated an infill sampling program targeting intervals not previously sampled for tungsten and gold throughout the Monument Bay deposit (“Monument Bay“) where tungsten could add a significant gold …

Read More »

Medicus Pharma Ltd. Completes Acquisition of Antev Limited

Antev is developing Teverelix, a next generation GnRH Antagonist, as a first in class market product for Acute Urinary Retention (AURr) and high CV risk Prostate Cancer collecting representing ~US$6 billion in potential market opportunity Patrick J. Mahaffy, a veteran pharma executive and the former Chairman of Antev, appointed to …

Read More »

Lara Signs Binding Letter of Intent for Its Itaituba Vanadium Project

Vancouver, British Columbia–(Newsfile Corp. – September 2, 2025) – Lara Exploration Ltd. (TSXV: LRA) (“Lara” or the “Company”) is pleased to report that it has signed a binding letter of intent with a non-reporting Ontario company (the “Optionee”), to fund further exploration and development of Lara’s Itaituba Vanadium Project (the “Project”), located …

Read More »

Soricimed Biopharma Inc. Strengthens Executive Team with Appointment of Dr. Michael Groaning PhD, as Chief Scientific Officer

Moncton, New Brunswick and Boston, Massachusetts–(Newsfile Corp. – September 2, 2025) – Soricimed Biopharma Inc. (“Soricimed”), a clinical-stage biopharmaceutical company focused on developing precision oncology drugs, today announced the appointment of Dr. Michael Groaning PhD, as Chief Scientific Officer (CSO). This strategic addition underscores Soricimed’s commitment to advancing its TRPV6-targeting …

Read More »

Atlas Critical Minerals’ Iron Quadrangle Project Expects Initial Revenues by Q4 2025

Strategic Partnership with Brazilian Iron Ore Processor Accelerates Path to Cash Flow Belo Horizonte, Brazil–(Newsfile Corp. – September 2, 2025) – Atlas Critical Minerals Corporation (OTCQB: JUPGF) (“Atlas Critical Minerals” or the “Company”) is pleased to report that its Iron Quadrangle Project (“Project”) expects to generate initial revenues in the …

Read More »

OS Therapies Provides OST-HER2 Recurrent, Fully Resected, Pulmonary Metastatic Osteosarcoma Program Update Following FDA End of Phase 2 Meeting

Company on track to begin submission of a rolling Biologics Licensing Application (BLA) request for OST-HER2 to U.S. Food & Drug Administration in September 2025 New York, New York–(Newsfile Corp. – September 2, 2025) – OS Therapies Inc. (NYSE American: OSTX) (“OS Therapies” or “the Company”), a clinical-stage cancer immunotherapy …

Read More »

Volta Announces Closing of Oversubscribed and Upsized Private Placement and Initiates Drilling Program at its Springer Rare Earth and Gallium Deposit

Toronto, Ontario–(Newsfile Corp. – September 2, 2025) – Volta Metals Ltd. (CSE: VLTA) (FSE: D0W) (“Volta” or the “Company“) is pleased to announce the closing of an oversubscribed non-brokered private placement for gross proceeds of $1,545,300 (the “Offering“). The Offering was comprised of the issuance of: (i) 8,441,250 units of …

Read More »

Kodiak Drills High-Grade Mineralization from Surface at the Adit Zone Including 79m of 0.69% CuEq Ending in 27m of 1.62% CuEq

Vancouver, British Columbia–(Newsfile Corp. – September 2, 2025) – Kodiak Copper Corp. (TSXV: KDK) (OTCQB: KDKCF) (FSE: 5DD1)  (the “Company” or “Kodiak“) announces additional drill results from the 2025 drill program at its 100% owned MPD copper-gold porphyry project in southern British Columbia. The program focused on short, near-surface infill and confirmation …

Read More »